Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells.
MRI evaluation of grey matter atrophy and disease course in multiple sclerosis: an overview of current knowledge.
Dopamine favors expansion of glucocorticoid-resistant IL-17-producing T cells in multiple sclerosis.
Allopregnanolone and neuroinflammation: a focus on multiple sclerosis.
Distribution of axon diameters in cortical white matter: an electron-microscopic study on three human brains and a macaque.
Ontogeny and Functions of Central Nervous System Macrophages.
Tamoxifen administration immediately or 24 hours after spinal cord injury improves locomotor recovery and reduces secondary damage in female rats.
Increased cortical grey matter lesion detection in multiple sclerosis with 7 T MRI: a post-mortem verification study.
A manic episode with psychotic features improved by methylprednisolone in a patient with multiple sclerosis.
A Case Study of Intractable Vomiting with Final Diagnosis of Neuromyelitis Optica.
Erratum to: Association Between the Single Nucleotide Polymorphism and the Level of Aquaporin-4 Protein Expression in Han and Minority Chinese with Inflammatory Demyelinating Diseases of the Central Nervous System.
Transverse myelitis in a patient with primary antiphospholipid syndrome.
Can a physician predict the clinical response to first-line immunomodulatory treatment in relapsing-remitting multiple sclerosis?
Increased Plasma Interleukin-32 Expression in Patients with Neuromyelitis Optica.
Experimental and therapeutic opportunities for stem cells in multiple sclerosis.
Primary progressive multiple sclerosis: progress and challenges.
Brain disorders where resources are scarce: The unfinished agenda.
The Immune Pathogenesis of Multiple Sclerosis.
Multiple sclerosis, an unlikely cause of chronic cerebrospinal venous insufficiency: retrospective analysis of catheter venography.
Cognitive Impairment in Multiple Sclerosis: A Forgotten Disability Remembered.
Retrieval practice is a robust memory aid for memory-impaired patients with MS.
The use of interferon Beta and glatiramer acetate in multiple sclerosis.
The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: Interleukin-17A and interleukin-17F serum levels.
Quality of life and patient preferences: identification of subgroups of multiple sclerosis patients.
Insight into the conformational polymorph transformation of a block-buster multiple sclerosis drug fingolimod hydrochloride (FTY 720).
Pages
« first
‹ previous
…
433
434
435
436
437
438
439
440
441
…
next ›
last »